Figure 1.
Schematic clinical practice guideline concepts adapted to summarize testing, detection, and management of CKD for primary care practitioners.14 ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; eGFR, estimated glomerular filtration rate; GLP-1 RA, glucagon-like peptide-1 receptor agonists; MRA mineralocorticoid receptor antagonist; SGLT-2i, sodium-glucose cotransporter-2 inhibitor; uACR, urine albumin-creatinine ratio. Adapted from Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2021;99:34–47.14 Copyright © 2020, Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. on behalf of the International Society of Nephrology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).